Pharmacokinetics and metabolism of topiramate

Drugs of Today

Volumn 35, Issue 1, 1999, Pages 43-48

  Bourgeois, Blaise F D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PROTEIN; TOPIRAMATE; VALPROIC ACID;

AREA UNDER THE CURVE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; REVIEW; TOTAL BODY WATER;

EID: 0033017662     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.1.522947     Document Type: Review

References (18)

1. Easterling, D.E., Zakzewski, T., Moyer, M.D. et al. Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia 1988, 29: 662.
2. Wu, W.N., Heebner, J.B., Streeter, A.J. et al. Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant topiramate in healthy men. Pharm Res 1994, 11 (Suppl.): 336.
3. Doose, D.R., Giscion, L.G., Stellar, S.M., Riffits, J.M., Hills, J.F. The effect of food on the bioavailability of topiramate from 100- and 400-mg tablets in healthy male subjects. Epilepsia 1992, 33 (Suppl. 3): 105.
4. Doose, D.R., Scott, V.V., MarguL B.L. Multiple dose pharmacokinetics of topiramate in healthy male subjects. Epilepsia 1988, 29: 662.
5. Pritchard, J.F. Binding of McN-4853 to plasma and erythrocytes of rat, mouse, rabbit, dog, monkey and human and to human serum. Data on file RW Johnson Pharm. Res. Inst., May 1985.
6. Giscion, L.G., Riffits, J.M., Sica, D.A., Gehr, T., Ruddley, J. The pharmacokinetics of topiramate in subjects with renal impairment as compared to matched subjects with normal renal function. Pharm Res 1993, 10 (Suppl.): 397.
7. Cloyd, J. Pharmacokinetic pitfalls of present antiepileptic medications. Epilepsia 1991, 32 (Suppl. 5): 53-65.
8. Bialer, M. Comparative pharmacokinetics of the newer antiepileptic drugs. Clin Pharmacokinet 1993, 24: 441-52.
9. Levy, R.H., Bishop, F., Streeter, A.J. et al. Explanation and prediction of drug interactions with topiramate using a CYP450 inhibition spectrum. Epilepsia 1995, 36 (Suppl. 4): 47.
10. Gisclon, L.G., Curtin, C.R., Kramer, L.D. The steady-state pharmacokinetics of phenytoin (Dilantin) and topiramate (Topamax) in epileptic patients on monotherapy and during combination therapy. Epilepsia 1994, 35 (Suppl. 8): 54.
11. Gisclon, L.G., Curtin, C.R., Kramer, L.D. A comparative study of the steady-state pharmacokinetics of phenytoin (Dilantin Kapseals brand) and of topiramate (Topamax) in male and female epileptic patients on monotherapy and during combination therapy. Pharm Res 1994, 11 (Suppl.): 445.
12. Doose, D.R., Walker, S.A., Sachdeo, R., Kramer, L.D. Nayak, R.K. Steady-state pharmacokinetics of Tegretol (carbamazepine) and Topamax (topiramate) in patients with epilepsy on monotherapy and during combination therapy. Epilepsia 1994, 35 (Suppl. 8): 54.
13. Sachdeo, R.C., Sachdeo, S.K., Walker, S.A., Kramer, L.D., Nayak, R.K., Doose, D.R. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1996, 37: 774-80.
14. Liao, S., Rosenfeld, W.E., Palmer, M. et al. Steady-state pharmacokinetics of topiramate and valproic acid in patients with epilepsy on monotherapy and during combination therapy. Epilepsia 1994, 35 (Suppl. 8): 117.
15. Liao, S., Rosenfeld, W.E., Palmer, M. et al. The steady-state pharmacokinetics of Topamax (topiramate) and valproic acid in patients with epilepsy on monotherapy and during combination therapy. Pharm Res 1994, 11 (Suppl.): 444.
16. Rosenfeld, W.E., Liao, S., Kramer, L.D. et al. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1997, 38: 324-33.
17. Liao, S., Palmer, M. Digoxin and topiramate drug interaction study in male volunteers. Pharm Res 1993, 10 (Suppl.): 405.
18. Rosenfeld, W.E., Doose, D.R., Walker, S.A., Nayak, R.K. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997, 38: 317-23.